The Schenergix HME A16 bridges the gap between pilot-scale development and full commercial production. Hot Melt Extrusion has transformed modern drug manufacturing by offering a solvent-free process that enhances drug solubility, stability, and delivery. The A16 supports both wet and dry granulation processes using HME, providing manufacturers with greater flexibility in formulation development.
Designed for process optimisation and mid-scale manufacturing, the A16 helps companies scale smoothly from research to market-ready production. With a throughput of up to 5 kg/h, it offers reliable performance while maintaining scalability and precision. Its modular design, ease of operation, and compatibility with auxiliary equipment such as chill-roll and pelletising units make it an efficient and versatile tool for continuous manufacturing environments.
Key Features include:
